Multimorbidity associated with anxiety symptomatology in post-COVID patients.
Multimorbidity associated with anxiety symptomatology in post-COVID patients.
复制标题
DOI：
10.1016/j.psychres.2022.114427
复制
发表时间：
2022-03
影响因子：
11.3
通讯作者：
Castro-de-Araujo LFS
中科院分区：
文献类型：
--
作者：
Azevedo MN;Rodrigues EDS;Passos EAFV;Filho MAB;Barreto APA;Lima MCC;Barreto ML;Castro-de-Araujo LFS
很少有研究描述人群，主要是低收入/中等收入国家的受寒后情况。多发病与焦虑症状显著相关。男性和年龄的增长降低了焦虑和抑郁的得分。新冠肺炎疫情对慢性病患者的打击最大。众所周知，在冠状病毒感染后的情况下，焦虑症状经常出现。我们想要检查多病是否与COVID后患者的焦虑有关。我们报告了389名COVID后患者的描述性统计数据，并与使用医院焦虑和抑郁(HAD)量表测量的焦虑症状进行了线性回归。对于每一种额外的慢性病，焦虑得分平均增加0.11。然而，随着年龄和男性的减少，这一比例有所下降。这些发现可能有助于政策制定者更好地组织冠状病毒感染后的卫生服务，并改善患者的护理。
Few studies have described post-covid conditions in a population, mainly de low/middle-income country. Multimorbidity was significantly associated with anxiety symptomatology. Being male and aging reduced the anxiety and depression score. The COVID-19 pandemic hit individuals with chronic conditions the hardest. It is known that anxiety symptoms are frequent in post-COVID conditions. We want to examine whether multimorbidity is associated with anxiety in post-COVID patients. We reported descriptive statistics from 389 post-COVID patients and perform a linear regression with anxiety symptoms measured using the Hospital Anxiety and Depression (HAD) scale. For each extra chronic condition, there was a mean increase of 0.11 in the HAD-anxiety score. However, there was a reduction for age and being male. These findings can potentially help policy-makers better organize post-COVID health services and improve patients care.
登录
查看更多内容
DOI：
10.1590/0102-311x00196120
发表时间：
2020-01-01
期刊：
Cadernos de Saúde Pública
影响因子：
--
作者：
Batista, Sandro Rodrigues;Souza, Ana Sara Semeão de;Nunes, Bruno Pereira
通讯作者：
Nunes, Bruno Pereira
影响因子：
2.8
作者：
Botega, NJ;Bio, MR;Pereira, WAB
通讯作者：
Pereira, WAB
影响因子：
4.7
作者：
Pieh C;Budimir S;Probst T
通讯作者：
Probst T
影响因子：
4.8
作者：
FOLSTEIN, MF;FOLSTEIN, SE;MCHUGH, PR
通讯作者：
MCHUGH, PR
影响因子：
6.7
作者：
ZIGMOND, AS;SNAITH, RP
通讯作者：
SNAITH, RP